| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.0M | +22.2% |
| Cost of Revenue | $30.1M | +22.9% |
| Gross Profit | $10.9M | +20.3% |
| R&D Expense | $64.3M | +86.0% |
| SG&A Expense | $61.2M | +17.8% |
| Operating Income | -$145.4M | -45.8% |
| Interest Expense | $2.7M | +434.5% |
| Pre-tax Income | -$138.3M | -42.9% |
| Income Tax | $305K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $122.9M | -32.7% |
| Accounts Receivable | $11.2M | +4.8% |
| Inventory | $19.5M | +162.3% |
| Current Assets | $162.5M | -21.6% |
| Total Assets | $256.1M | -16.8% |
| Current Liabilities | $29.5M | +33.4% |
| Long-term Debt | $39.6M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110.7M | -55.8% |
| Capital Expenditures | $5.4M | +26.6% |
| Investing Cash Flow | -$5.1M | +66.2% |
| Financing Cash Flow | $55.6M | -78.5% |
| Free Cash Flow | -$116.1M | -54.1% |
| +110.9% |
| Net Income | -$138.6M | -47.4% |
| EPS (Basic) | -$0.78 | -11.4% |
| EPS (Diluted) | -$0.78 | -11.4% |
| Total Liabilities |
| $84.5M |
| +79.8% |
| Stockholders' Equity | $171.6M | -34.2% |